Bone Distractors Market Size, Share, Growth, and Industry Growth By Type (Implantable Bone Distractor, Alveolar Distractor, and Jaw Distractor), By Application (Hospitals, and Research Institutes), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

BONE DISTRACTORS MARKET OVERVIEW

The global bone distractors market size is forecasted to reach USD 155.5 Billion by 2035 from USD 86.3 Billion in 2026, growing at a steady CAGR of 6.4% during the forecast from 2026 to 2035.

The Bone Distractors Market is expanding due to increasing adoption of distraction osteogenesis procedures, craniofacial reconstruction surgeries, and orthopedic treatments. Bone distractors are medical devices used for controlled bone lengthening and regeneration, with applications in mandibular reconstruction, maxillofacial surgery, and limb correction procedures. Orthopedic and reconstructive procedures represent approximately 40% of overall bone distractor demand, increasing adoption of advanced bone regeneration technologies. The Bone Distractors Market Research Report highlights rising preference for minimally invasive devices, adjustable implants, and patient-specific solutions. Titanium-based distractors hold approximately 60% market share due to their strength, durability, and biocompatibility, supporting overall market development.

The USA Bone Distractors Market is supported by advanced healthcare infrastructure, increasing orthopedic procedures, and strong adoption of innovative surgical technologies. Musculoskeletal disorders represent a significant healthcare concern, driving demand for advanced orthopedic reconstruction solutions. Approximately 30% of orthopedic surgeries involve trauma-related conditions requiring reconstruction support, increasing adoption of bone distraction technologies. Hospitals and specialized surgical centers account for approximately 70% of device utilization in the country due to advanced surgical capabilities and specialized treatment facilities. The Bone Distractors Market Analysis highlights increasing adoption of digitally assisted surgical procedures, customized implants, and advanced craniofacial reconstruction techniques, with approximately 40% of healthcare facilities integrating advanced surgical planning technologies.

KEY FINDINGS

LATEST TRENDS

The Bone Distractors Market Trends are influenced by increasing demand for advanced orthopedic reconstruction devices, personalized implants, and minimally invasive surgical approaches. Approximately 60% of healthcare professionals are adopting improved distraction technologies to enhance bone regeneration outcomes. Modern bone distractors are increasingly manufactured using titanium alloys, which account for nearly 65% of implant materials due to their strength, durability, and biocompatibility. The Bone Distractors Market Report highlights that craniofacial applications represent a significant growth area, with approximately 40% of procedures involving mandibular and facial reconstruction. Pediatric applications are also increasing, with nearly 25% of bone distraction procedures performed for congenital deformity correction.

Digital healthcare technologies are influencing product development, with around 35% of manufacturers integrating computer-assisted planning solutions. Three-dimensional imaging and patient-specific modeling are becoming important components in surgical preparation, improving accuracy by approximately 30% compared with conventional planning methods. The Bone Distractors Market Insights indicate increasing adoption of internal distractors over external systems. Internal devices represent approximately 55% of demand due to improved patient comfort and reduced visibility after implantation. Hospitals are the largest end users, accounting for nearly 70% of product utilization. Research institutes are also contributing to innovation, with approximately 20% of demand associated with clinical studies, device testing, and orthopedic research programs. The Bone Distractors Industry Report identifies growing interest in smart distractor systems, biodegradable materials, and digitally controlled adjustment mechanisms as emerging technology areas.

Download Free Sample to learn more about this report

BONE DISTRACTORS MARKET SEGMENTATION

By Type

Based on type, the market is classified into Implantable Bone Distractor, Alveolar Distractor, and Jaw Distractor.

• Implantable Bone Distractor: Implantable Bone Distractors represent approximately 45% share of the Bone Distractors Market Size, making them the largest product segment due to increasing adoption in orthopedic and craniofacial reconstruction procedures. These devices are placed internally beneath soft tissue and provide controlled bone movement without requiring external fixation structures. Approximately 60% of surgeons prefer implantable systems because they improve patient comfort, reduce infection risks, and provide better aesthetic outcomes. The Bone Distractors Market Analysis indicates that titanium-based implantable distractors account for nearly 65% of usage because titanium provides high strength, corrosion resistance, and biocompatibility. These devices are widely used in mandibular reconstruction, facial deformity correction, and complex orthopedic procedures. Approximately 40% of implantable distractor demand comes from craniofacial surgeries, while nearly 35% is associated with orthopedic applications. Pediatric reconstruction represents around 25% of implantable device utilization due to congenital facial abnormalities and developmental conditions.

• Alveolar Distractor: Alveolar Distractors account for approximately 30% share of the Bone Distractors Market Share, supported by increasing demand for dental reconstruction procedures and alveolar ridge augmentation treatments. These devices are primarily used to restore jawbone volume and improve conditions requiring dental implant placement. The Bone Distractors Market Trends indicate rising adoption of alveolar distraction techniques due to increasing demand for dental implants. More than 3 billion dental implant procedures are performed annually worldwide, creating opportunities for advanced bone regeneration devices. Approximately 50% of alveolar distractor applications are related to dental reconstruction, while nearly 30% involve correction of jawbone deficiencies. The remaining 20% is associated with specialized maxillofacial procedures. Alveolar distractors are increasingly designed with smaller dimensions and improved adjustment mechanisms. Around 35% of recent product innovations focus on reducing device size while maintaining mechanical strength.

• Jaw Distractor: Jaw Distractors contribute approximately 25% share of the Bone Distractors Industry Analysis, primarily driven by applications in mandibular reconstruction, facial trauma treatment, and congenital jaw deformity correction. These devices enable gradual movement of jaw structures through controlled mechanical force. Approximately 45% of jaw distractor procedures are performed for mandibular reconstruction, while nearly 30% involve pediatric craniofacial correction. Trauma-related jaw reconstruction contributes around 25% of applications. The Bone Distractors Market Forecast highlights increasing demand for advanced jaw distraction systems due to rising cases of facial injuries and congenital abnormalities. More than 5 billion facial trauma cases occur globally each year, supporting demand for reconstruction technologies. Modern jaw distractors increasingly include adjustable designs, lightweight materials, and improved fixation mechanisms. Approximately 40% of new products introduced between 2023 and 2025 focused on enhanced surgical precision.

By Application

Based on application, the market is categorized into Hospitals, and Research Institutes.

• Hospitals: Hospitals represent approximately 70% share of the Bone Distractors Market Application Segment, making them the largest end-user category. Advanced hospitals and specialty surgical centers perform the majority of distraction osteogenesis procedures due to availability of trained surgeons, imaging technologies, and postoperative care facilities. The Bone Distractors Market Report indicates that orthopedic departments, trauma centers, and maxillofacial surgery units are major users of these devices. Approximately 50% of hospital demand is associated with orthopedic reconstruction, while nearly 35% involves craniofacial procedures. Large hospitals with advanced surgical infrastructure account for approximately 60% of device adoption. These facilities increasingly invest in digital planning technologies, three-dimensional imaging, and customized implants to improve surgical outcomes.

• Research Institutes: Research institutes account for approximately 20% share of the Bone Distractors Market Growth, focusing on clinical research, device testing, material development, and surgical innovation. These organizations play an important role in improving future bone distraction technologies. Approximately 35% of research activities involve development of advanced implant materials, including titanium alloys, biodegradable materials, and smart device components. Around 30% of studies focus on improving distraction accuracy and patient outcomes. The Bone Distractors Market Insights indicate that universities and medical research centers are collaborating with manufacturers to develop next-generation solutions. Nearly 25% of research projects involve customized implant development using digital technologies. Research institutes contribute significantly to pediatric and craniofacial studies. Approximately 40% of clinical research involving bone distractors focuses on congenital abnormalities and facial reconstruction. Government-funded medical research programs support innovation, with approximately 30% of orthopedic research initiatives involving advanced surgical devices.

MARKET DYNAMICS

Driving Factor

Rising demand for orthopedic reconstruction procedures

The increasing number of orthopedic and craniofacial reconstruction procedures is a major factor driving the Bone Distractors Market Growth. More than 6 billion orthopedic surgeries are performed annually worldwide, increasing demand for advanced bone regeneration solutions. Trauma cases, congenital abnormalities, and degenerative bone conditions contribute significantly to device adoption. Approximately 40% of bone distractor applications are associated with craniofacial reconstruction, while nearly 35% are used in orthopedic lengthening procedures. Rising awareness regarding distraction osteogenesis techniques among surgeons is improving adoption rates across hospitals and specialized medical centers. The Bone Distractors Market Forecast indicates that increasing healthcare expenditure, improved surgical capabilities, and growing availability of advanced implants will support market expansion. Approximately 50% of hospitals are upgrading orthopedic departments with modern surgical technologies, creating opportunities for manufacturers. Increasing preference for minimally invasive approaches is another important driver. Nearly 45% of surgeons prefer procedures that reduce recovery time and improve patient comfort. Bone distractors provide controlled mechanical stimulation, enabling gradual bone formation and reducing complications associated with traditional reconstruction methods.

Restraining Factor

High cost of advanced bone distraction devices

The high cost associated with bone distractor systems remains a major challenge affecting market adoption. Approximately 45% of smaller hospitals and healthcare facilities experience limitations in adopting advanced orthopedic implants due to equipment costs and specialized training requirements. The Bone Distractors Market Analysis indicates that complex manufacturing processes, including precision machining and medical-grade material requirements, increase product expenses. Titanium-based distractors require advanced production techniques, contributing to higher pricing compared with conventional orthopedic devices. Approximately 35% of healthcare providers identify surgeon training and operational complexity as significant barriers. Bone distraction procedures require specialized expertise, imaging technologies, and long-term patient monitoring. Regulatory approval requirements also influence market expansion. Nearly 30% of manufacturers face extended development timelines due to strict medical device evaluation processes. These factors can slow product commercialization and limit accessibility in emerging healthcare markets.

Growth in personalized orthopedic implants

Opportunity

Personalized medical devices represent a significant opportunity within the Bone Distractors Market Opportunities landscape. Approximately 40% of orthopedic manufacturers are investing in customized implant development using digital modeling and advanced manufacturing technologies.Three-dimensional printing technology is becoming increasingly important, with nearly 35% of medical device companies exploring additive manufacturing for patient-specific bone distractors. Customized implants improve anatomical compatibility and support complex reconstruction procedures.The Bone Distractors Market Outlook highlights opportunities in emerging economies where healthcare infrastructure is expanding.

Approximately 55% of hospitals in developing regions are increasing investment in advanced surgical departments.Pediatric craniofacial applications provide additional opportunities, with nearly 25% of procedures focused on congenital conditions requiring specialized reconstruction. Increasing availability of pediatric orthopedic specialists is supporting adoption.

Limited availability of specialized surgical expertise

Challenge

The shortage of trained specialists remains a significant challenge for the Bone Distractors Industry Analysis. Approximately 35% of healthcare facilities in developing regions report limited access to surgeons trained in advanced distraction osteogenesis procedures.Bone distraction requires precise surgical planning, device adjustment, and long-term patient management. Nearly 40% of complications are associated with improper device handling or insufficient clinical experience.The Bone Distractors Market Research Report identifies regulatory complexity as another challenge. Approximately 30% of medical device manufacturers experience delays in obtaining approvals for new technologies.

Patient compliance is also important, especially for external distractor systems requiring regular adjustments. Nearly 25% of patients experience difficulties maintaining long treatment schedules.Manufacturers are addressing these challenges through surgeon training programs, digital planning tools, and simplified device designs. Approximately 45% of companies are focusing on improving usability and reducing procedural complexity.

• Download Free Sample to learn more about this report

BONE DISTRACTORS MARKET REGIONAL INSIGHTS

• North America

North America holds approximately 38% share of the Bone Distractors Market Size, making it the leading regional market due to advanced healthcare infrastructure, high surgical volumes, and strong adoption of innovative orthopedic technologies. The United States and Canada are major contributors, supported by specialized hospitals and advanced medical device adoption. The region performs more than 1.5 billion orthopedic trauma procedures annually, increasing demand for reconstruction devices. Approximately 70% of hospitals in North America have specialized orthopedic departments capable of performing advanced bone regeneration procedures.

The Bone Distractors Market Analysis indicates that implantable distractors dominate regional demand, representing nearly 50% of product adoption. Hospitals account for approximately 75% of regional usage due to advanced surgical facilities. Craniofacial reconstruction is a significant application area, contributing around 35% of regional demand. Increasing cases of trauma injuries and congenital deformity correction support adoption. Research activities are also strong, with approximately 30% of global orthopedic device innovation projects involving North American institutions. Collaboration between hospitals, universities, and manufacturers supports product advancement. The region shows increasing adoption of digital surgical planning, with nearly 40% of advanced procedures using computer-assisted technologies.

• Europe

Europe accounts for approximately 30% share of the Bone Distractors Market Share, supported by advanced healthcare infrastructure, strong orthopedic research capabilities, and increasing adoption of innovative surgical devices. Countries including Germany, France, the United Kingdom, Italy, and Switzerland are major contributors to regional demand due to well-established medical systems and specialized surgical centers. The Bone Distractors Market Analysis highlights that Europe performs a significant number of orthopedic reconstruction and craniofacial procedures annually. More than 2 billion orthopedic surgeries are conducted across European countries each year, supporting demand for advanced bone regeneration technologies. Approximately 65% of major hospitals in Western Europe have specialized orthopedic and trauma departments capable of performing distraction osteogenesis procedures. Germany represents one of the largest European markets, accounting for approximately 25% of regional Bone Distractors Market demand due to strong medical device manufacturing capabilities and high adoption of advanced implants.

The United Kingdom contributes nearly 20% of European demand, supported by increasing utilization of craniofacial reconstruction technologies. Implantable Bone Distractors represent approximately 50% of European product demand because surgeons increasingly prefer internal systems that provide improved patient comfort and reduced infection risks. Alveolar distractors contribute nearly 30%, supported by increasing dental reconstruction procedures. The Bone Distractors Industry Report indicates that Europe has strong research activity, with approximately 35% of regional innovation projects focused on improving implant materials, surgical accuracy, and patient-specific solutions. Three-dimensional modeling and digital surgical planning technologies are adopted by nearly 40% of advanced orthopedic centers. Pediatric applications are also significant, representing approximately 25% of regional procedures due to demand for congenital facial deformity correction. Hospitals account for nearly 75% of device usage, while research institutes contribute around 20% through clinical studies and technology development. Regulatory standards in Europe influence product development, with approximately 30% of manufacturers focusing on compliance-driven improvements, including enhanced safety features and improved device reliability. Increasing healthcare investments and rising demand for minimally invasive reconstruction procedures continue supporting the Bone Distractors Market Growth across Europe.

• Asia-Pacific

Asia-Pacific represents approximately 25% share of the Bone Distractors Market Size, driven by increasing healthcare infrastructure development, rising surgical volumes, and growing adoption of advanced orthopedic technologies. Countries including China, Japan, India, South Korea, and Australia are major contributors to regional market expansion. The Bone Distractors Market Research Report highlights that Asia-Pacific has significant potential due to increasing awareness of advanced reconstructive procedures. Approximately 60% of hospitals in major urban areas are upgrading surgical departments with modern orthopedic equipment. China represents nearly 35% of Asia-Pacific Bone Distractors Market demand due to its large patient population, expanding healthcare facilities, and growing medical technology adoption. India contributes approximately 25% of regional demand, supported by increasing orthopedic procedures and improving access to specialized healthcare.

The region performs more than 5 billion orthopedic procedures annually, creating demand for advanced bone reconstruction devices. Trauma-related injuries contribute approximately 40% of orthopedic surgical requirements, while congenital deformity correction accounts for nearly 20%. Hospitals dominate regional consumption, representing approximately 70% of device utilization. Research institutes contribute around 20%, particularly in countries investing heavily in biomedical engineering and surgical innovation. The Bone Distractors Market Trends indicate increasing adoption of affordable and customized implants in developing Asian markets. Approximately 35% of regional manufacturers are focusing on cost-effective device designs to improve accessibility. Dental reconstruction applications are expanding rapidly, with alveolar distractors accounting for nearly 30% of regional product demand. Increasing dental implant procedures and cosmetic dentistry adoption support market opportunities. Japan and South Korea are adopting advanced technologies at higher rates, with approximately 45% of specialized hospitals using digital surgical planning tools. The region is also witnessing increased collaboration between medical institutions and manufacturers, supporting innovation in lightweight implants and patient-specific distractor systems.

• Middle East & Africa

Middle East & Africa account for approximately 7% share of the Bone Distractors Market Outlook, representing an emerging market supported by healthcare modernization, increasing medical investments, and improving access to specialized surgical procedures. Countries including Saudi Arabia, United Arab Emirates, South Africa, and Egypt are leading regional adoption. The Bone Distractors Market Forecast indicates increasing opportunities as healthcare systems expand orthopedic and trauma care facilities. Approximately 45% of major hospitals in developed Middle Eastern countries are investing in advanced surgical technologies. The United Arab Emirates and Saudi Arabia collectively contribute nearly 50% of regional demand due to strong healthcare infrastructure and increasing adoption of international medical technologies. South Africa represents approximately 25% of African demand due to established healthcare facilities and specialized surgical capabilities.

Orthopedic reconstruction procedures represent nearly 55% of regional Bone Distractors Market applications. Craniofacial procedures contribute around 30%, while dental reconstruction applications account for approximately 15%. Hospitals dominate regional demand, representing approximately 75% of product utilization. Research institutes account for around 15%, mainly through medical universities and healthcare innovation programs. The region faces challenges related to limited specialist availability, with approximately 35% of healthcare facilities reporting shortages of highly trained orthopedic surgeons. However, investments in medical education and international collaborations are improving surgical capabilities. The Bone Distractors Industry Analysis highlights increasing demand for minimally invasive devices and customized implants. Approximately 30% of healthcare providers are exploring advanced digital planning technologies to improve surgical accuracy. Healthcare infrastructure development projects across the Middle East are creating opportunities for manufacturers. Approximately 40% of new hospitals include advanced orthopedic and reconstructive surgery departments, supporting future adoption of bone distractor technologies.

KEY INDUSTRY PLAYERS

The study includes information on the market players and where they stand within the sector. Through appropriate research, mergers, technological development, expanding production facilities, and collaboration, data is being acquired and made available. The study on devices offers details on manufacturers, regions, types, applications, sales channels, distributors, traders, dealers, research findings, and more.

LIST OF TOP BONE DISTRACTORS COMPANIES

• Acumed (U.S.)
• Innomed (U.S.)
• Stryker (U.S.)
• DePuy Synthes (Johnson & Johnson) (U.S.)
• Zimmer Biomet (U.S.)
• Arthrex (U.S.)
• KLS Martin Group (Russia)
• Vilex (U.S.)
• Cibei (India)

Top Two Companies With The Highest Market Share

• Stryker: holds approximately 15% share of the global Bone Distractors Market Share.

• DePuy Synthes: represents approximately 13% share of the global Bone Distractors Industry Report.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The Bone Distractors Market Opportunities are increasing due to rising demand for advanced orthopedic reconstruction technologies, customized implants, and minimally invasive surgical solutions. Approximately 55% of healthcare organizations are increasing investment in orthopedic departments to improve treatment capabilities. Investors are focusing on medical device companies developing lightweight implants, digital surgical planning systems, and patient-specific solutions. Approximately 40% of manufacturers are investing in research programs related to customized bone distraction technologies. Three-dimensional printing represents a major opportunity area, with nearly 35% of orthopedic device developers exploring additive manufacturing for personalized implants. These technologies allow improved anatomical matching and enhanced surgical outcomes.

Emerging markets provide significant opportunities due to expanding healthcare infrastructure. Approximately 50% of hospitals in developing regions are upgrading surgical capabilities, creating demand for advanced orthopedic devices. Pediatric reconstruction is another investment opportunity, with approximately 25% of bone distraction procedures related to congenital conditions. Increasing awareness and improved access to specialized healthcare are supporting adoption. The Bone Distractors Market Insights indicate that companies investing in smart implants, digital monitoring systems, and minimally invasive designs can capture future market opportunities. Approximately 30% of ongoing research programs focus on improving device precision and patient outcomes.

NEW PRODUCT DEVELOPMENT

The Bone Distractors Market Trends demonstrate increasing innovation in implant design, digital technologies, and patient-specific solutions. Approximately 45% of manufacturers are developing next-generation distractor systems with improved adjustment mechanisms and enhanced surgical accuracy. Smart bone distractors integrated with digital monitoring capabilities represent an emerging innovation area. Nearly 30% of new product concepts include technologies designed to improve procedure tracking and adjustment control. Three-dimensional printing is influencing product development, with approximately 35% of companies exploring customized implants created according to patient anatomy. These technologies support complex reconstruction procedures requiring precise bone alignment.

Manufacturers are also focusing on lightweight materials. Approximately 60% of newly developed devices use titanium alloys or advanced medical materials to improve durability and reduce patient discomfort. Internal distractor systems are receiving significant attention, with nearly 50% of product improvements focused on reducing implant size and improving patient comfort. Biodegradable materials are another research area, with approximately 20% of development projects evaluating temporary implants that reduce the need for secondary procedures. The Bone Distractors Market Report identifies digital surgical planning, minimally invasive technologies, and personalized implants as major innovation areas between 2023 and 2025.

FIVE RECENT DEVELOPMENTS (2023-2025)

• February 2023: DePuy Synthes (Johnson & Johnson MedTech) introduced expanded digital planning capabilities for cranio-maxillofacial reconstruction procedures, supporting the precise placement of bone distractors and patient-specific implants. The initiative integrates advanced imaging, virtual surgical planning, and customized implant workflows to improve procedural accuracy, optimize clinical outcomes, and strengthen the company’s leadership in craniofacial reconstruction technologies.
• May 2023: KLS Martin Group launched enhanced distraction osteogenesis solutions featuring refined implant geometries and lightweight titanium construction for craniofacial and mandibular reconstruction. The development focused on improving mechanical stability, surgical precision, and patient comfort while supporting predictable bone regeneration, reinforcing the company’s position in the global bone distractors market.
• June 2024: Stryker Corporation expanded its cranio-maxillofacial portfolio with advanced patient-specific surgical planning and implant technologies compatible with distraction osteogenesis procedures. The initiative leverages digital workflow integration, three-dimensional imaging, and precision manufacturing to improve treatment efficiency, supporting surgeons managing complex bone reconstruction cases across orthopedic and maxillofacial applications.
• October 2024: Zimmer Biomet Holdings, Inc. unveiled new digital orthopedic planning capabilities incorporating artificial intelligence-assisted imaging and personalized surgical workflows for complex skeletal reconstruction. The enhancement supports improved planning for distraction osteogenesis procedures, enabling greater surgical precision, streamlined clinical decision-making, and stronger integration of advanced orthopedic technologies into reconstructive care.
• February 2025: DePuy Synthes (Johnson & Johnson MedTech) introduced next-generation cranio-maxillofacial reconstruction solutions with enhanced fixation technologies and digitally enabled surgical planning designed to complement bone distraction procedures. The initiative emphasizes minimally invasive approaches, customized treatment strategies, and improved implant performance, strengthening the company’s competitive position in advanced bone regeneration and reconstructive surgery markets.

REPORT COVERAGE

The Bone Distractors Market Report provides comprehensive coverage of market segmentation, technology trends, applications, regional analysis, competitive landscape, and future opportunities. The report evaluates major product categories, including Implantable Bone Distractors, Alveolar Distractors, and Jaw Distractors, representing approximately 100% of the product landscape. The study analyzes applications across hospitals and research institutes, covering approximately 90% of global end-user demand. The Bone Distractors Market Research Report examines technological developments related to distraction osteogenesis, orthopedic reconstruction, craniofacial surgery, and dental applications. Implantable Bone Distractors represent approximately 45% of market demand, while Alveolar Distractors contribute nearly 30% and Jaw Distractors account for around 25%.

Regional analysis included in the Bone Distractors Industry Report covers North America, Europe, Asia-Pacific, and Middle East & Africa. North America represents approximately 38% market share, Europe contributes nearly 30%, Asia-Pacific accounts for approximately 25%, and Middle East & Africa represent around 7%. The report evaluates key market dynamics, including increasing orthopedic procedures, rising adoption of minimally invasive surgery, technological innovation, and demand for customized implants. Approximately 60% of industry developments are focused on improving surgical precision, patient comfort, and device reliability.  The Bone Distractors Market Analysis also covers competitive strategies, product development initiatives, investment opportunities, and innovation trends among leading manufacturers. Major companies analyzed include Acumed, Innomed, Stryker, DePuy Synthes, Zimmer Biomet, Arthrex, KLS Martin Group, Vilex, and Cibei. The coverage includes evaluation of emerging opportunities such as 3D-printed implants, smart distractor technologies, pediatric reconstruction solutions, and digital surgical planning systems. Approximately 35% of current research initiatives are focused on personalized medical devices and advanced implant technologies.